切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2021, Vol. 17 ›› Issue (06) : 621 -626. doi: 10.3877/cma.j.issn.1673-5250.2021.06.001

专题论坛

胎儿病理(尸检)研究现状与展望
邹娟, 张梦兰, 王巍()   
  • 收稿日期:2021-06-01 修回日期:2021-09-15 出版日期:2021-12-01
  • 通信作者: 王巍

Current research status and prospect of fetal pathology (autopsy)

Juan Zou, Menglan Zhang, Wei Wang()   

  • Received:2021-06-01 Revised:2021-09-15 Published:2021-12-01
  • Corresponding author: Wei Wang
  • Supported by:
    Applied Basic Research Project of Science and Technology Department of Sichuan Province(2019YJ0065)
引用本文:

邹娟, 张梦兰, 王巍. 胎儿病理(尸检)研究现状与展望[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(06): 621-626.

Juan Zou, Menglan Zhang, Wei Wang. Current research status and prospect of fetal pathology (autopsy)[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2021, 17(06): 621-626.

胎儿尸检是胎儿病理的主要诊断和研究方法,在胎儿医学中扮演着非常重要的角色,主要是在探究胎儿生长、发育异常,判断其死亡原因、遗传综合征及评估不良妊娠复发风险。随着我国三胎政策的放开,高龄产妇随之增加,胎儿医学也为胎儿病理学对胎儿生长、发育异常的诊断提出更高要求,这对于传统诊断病理学而言,既是挑战也是机遇。笔者拟就胎儿病理(尸检)的研究现状与困境、未来与突破,特别是对可能取得的突破性进展进行展望,旨在为从事胎儿医学相关研究的临床工作者提供参考和依据。

Fetal autopsy is one of the main inspection methods to explore growth, death, genetic syndromes and adverse outcomes of fetus, it plays a very important role in fetal medicine. With the liberalization of the three-child policy in China, the number of older parturients will increase accordingly. Fetal medicine also puts forward higher requirements for diagnosis of fetal pathology, which is a challenge and an opportunity for development of fetal pathology. This article discusses current status and dilemma of fetal pathology, the future and breakthroughs, and prospects for possible breakthroughs, in hope of providing reference and basis for fetal medical workers engaged in related research in the future.

[1]
Ernst LM. A pathologist′s perspective on the perinatal autopsy[J]. Semin Perinatol, 2015, 39(1): 55-63. DOI: 10.1053/j.semperi.2014.10.008.
[2]
Auger N, Bilodeau-Bertrand M, Poissant J, et al. Decreasing use of autopsy for stillbirths and infant deaths: missed opportunity[J]. J Perinatol, 2018, 38(10): 1414-1419. DOI: 10.1038/s41372-018-0191-y.
[3]
De Sévaux JLH, Nikkels PGJ, Lequin MH, et al. The value of autopsy in neonates in the 21st century[J]. Neonatology, 2019, 115(1): 89-93. DOI: 10.1159/000493003.
[4]
Lewis C, Hill M, Arthurs OJ, et al. Factors affecting uptake of postmortem examination in the prenatal, perinatal and paediatric setting[J]. BJOG, 2018, 125(2):172-181. DOI: 10.1111/1471-0528.14600.
[5]
Meaney S, Gallagher S, Lutomski JE, et al. Parental decision making around perinatal autopsy: a qualitative investigation[J]. Health Expect, 2015, 18(6): 3160-3171. DOI: 10.1111/hex.12305.
[6]
American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine, Metz TD, et al. Management of stillbirth. Obstetric care consensus No. 10[J]. Obstet Gynecol, 2020, 135(3): e110-e132. DOI: 10.1097/AOG.0000000000003719.
[7]
Deng Y, Wang R, Zhou X, et al. Fetal, neonatal, and infant death in central China (Hubei): a 16-year retrospective study of forensic autopsy cases[J]. Medicine (Baltimore), 2019, 98(23): e15788. DOI: 10.1097/MD.0000000000015788.
[8]
Venkataswamy C, Gurusamy U, Lakshmi SV. Second-trimester fetal autopsy: a morphological study with prenatal USG correlations and clinical implications[J]. J Lab Physicians, 2018, 10(3): 338-345. DOI: 10.4103/JLP.JLP_134_17.
[9]
Xu CP, Ge XD, Li XL, et al. Clinical pathologic analysis for congenital malformations in 438 cases of fetal and perinatal autopsy[J]. J Third Mil Med Univ, 2012, 34(2): 113-115. DOI:10.16016/j.1000-5404.2012.02.020.
[10]
Miller ES, Minturn L, Linn R, et al. Stillbirth evaluation: a stepwise assessment of placental pathology and autopsy[J]. Am J Obstet Gynecol, 2016, 214(1): 115.e1-115.e6. DOI: 10.1016/j.ajog.2015.08.049.
[11]
Gordijn SJ, Erwich JJ, Khong TY. Value of the perinatal autopsy: critique[J]. Pediatr Dev Pathol, 2002, 5(5): 480-488. DOI: 10.1007/s10024-002-0008-y.
[12]
Duval H, Michel-Calemard L, Gonzales M, et al. Fetal anomalies associated with HNF1B mutations: report of 20 autopsy cases[J]. Prenat Diagn, 2016, 36(8):744-751. DOI: 10.1002/pd.4858.
[13]
Hui P, Buza N, Murphy KM, et al. Hydatidiform moles: genetic basis and precision diagnosis[J]. Annu Rev Pathol, 2017, 24(12): 449-485. DOI: 10.1146/annurev-pathol-052016-100237.
[14]
Ptacek I, Sebire NJ, Man JA, et al. Systematic review of placental pathology reported in association with stillbirth[J]. Placenta, 2014, 35(8): 552-562. DOI: 10.1016/j.placenta.2014.05.011.
[15]
Zhou XR. The significance and essential principles of placental pathology[J]. Chin J Pathol, 2020, 49(8): 779-781. DOI: 10.3760/cma.j.cn112151-20200604-00446.
[16]
Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: amsterdam placental workshop group consensus statement[J]. Arch Pathol Lab Med, 2016, 140(7): 698-713. DOI: 10.5858/arpa.2015-0225-CC.
[17]
Shen JD, Sun FX, Zhai DY, et al. Chromosome abnormality rate and related factors of spontaneous abortion in early pregnancy[J]. Chin J Obstet Gynecol, 2019, 54(12): 797-802. DOI: 10.3760/cma.j.issn.0529-567x.2019.12.002.
[18]
Best S, Wou K, Vora N, et al. Promises, pitfalls and practicalities of prenatal whole exome sequencing[J]. Prenat Diagn, 2018, 38(1): 10-19. DOI: 10.1002/pd.5102.
[19]
Armes JE, Williams M, Price G, et al. Application of whole genome sequencing technology in the investigation of genetic causes of fetal, perinatal, and early infant death[J]. Pediatr Dev Pathol, 2018, 21(1): 54-67. DOI: 10.1177/1093526617715528.
[20]
Wojcik MH, Brodsky D, Stewart JE, et al. Peri-mortem evaluation of infants who die without a diagnosis: focus on advances in genomic technology[J]. J Perinatol, 2018, 38(9): 1125-1134. DOI: 10.1038/s41372-018-0187-7.
[21]
Meng L, Pammi M, Saronwala A, et al. Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management[J]. JAMA Pediatr, 2017, 171(12): e173438. DOI: 10.1001/jamapediatrics.2017.3438.
[22]
Matsika A, Gallagher R, Williams M, et al. DNA extraction from placental, fetal and neonatal tissue at autopsy: what organ to sample for DNA in the genomic era?[J]. Pathology, 2019, 51(7):705-710. DOI: 10.1016/j.pathol.2019.09.001.
[23]
Shamseldin HE, Kurdi W, Almusafri F, et al. Molecular autopsy in maternal-fetal medicine[J]. Genet Med, 2018, 20(4): 420-427. DOI: 10.1038/gim.2017.111.
[24]
Menendez C, Castillo P, Martínez MJ, et al. Validity of a minimally invasive autopsy for cause of death determination in stillborn babies and neonates in Mozambique: an observational study[J]. PLoS Med, 2017, 14(6):e1002318. DOI: 10.1371/journal.pmed.1002318.
[25]
Breeze AC, Jessop FA, Whitehead AL, et al. Feasibility of percutaneous organ biopsy as part of a minimally invasive perinatal autopsy[J]. Virchows Arch, 2008, 452(2): 201-207. DOI: 10.1007/s00428-007-0548-7.
[26]
Hutchinson JC, Shelmerdine SC, Lewis C, et al. Minimally invasive perinatal and pediatric autopsy with laparoscopically assisted tissue sampling: feasibility and experience of the minimal procedure[J]. Ultrasound Obstet Gynecol, 2019, 54(5): 661-669. DOI: 10.1002/uog.20211.
[27]
Kang X, Shelmerdine SC, Hurtado I, et al. Postmortem examination of human fetuses: comparison of two-dimensional ultrasound with invasive autopsy[J]. Ultrasound Obstet Gynecol, 2019, 53(2): 229-238. DOI: 10.1002/uog.18828.
[28]
Votino C, Cos Sanchez T, Bessieres B, et al. Minimally invasive fetal autopsy using ultrasound: a feasibility study[J]. Ultrasound Obstet Gynecol, 2018, 52(6): 776-783. DOI: 10.1002/uog.14642.
[29]
Hutchinson JC, Kang X, Shelmerdine SC, et al. Postmortem microfocus computed tomography for early gestation fetuses: a validation study against conventional autopsy[J]. Am J Obstet Gynecol, 2018, 218(4): 445.e1-445.e12. DOI: 10.1016/j.ajog.2018.01.040.
[30]
Shelmerdine SC, Gerrard CY, Rao P, et al. Joint European Society of Paediatric Radiology (ESPR) and International Society of Forensic Radiology and Imaging (ISFRI) guidelines: paediatric postmortem computed tomography imaging protocol[J]. Pediatr Radiol, 2019, 49(5):694-701. DOI: 10.1007/s00247-018-04340-x.
[31]
Jalalzadeh H, Giannakopoulos GF, Berger FH, et al. Post-mortem imaging compared with autopsy in trauma victims: a systematic review[J]. Forensic Sci Int, 2015, 257: 29-48. DOI: 10.1016/j.forsciint.2015.07.026.
[32]
张恒,宁刚. 《美国胎儿影像指南(2014)》胎儿MRI检查部分解读[J/CD]. 中华妇幼临床医学杂志(电子版), 2017, 13 (3): 276-280. DOI: 10.3877/cma.j.issn.1673-5250.2017.03.006.
[33]
Shruthi M, Gupta N, Jana M, et al. Conventional vs virtual autopsy with postmortem MRI in phenotypic characterization of stillbirths and fetal malformations[J]. Ultrasound Obstet Gynecol, 2018, 51(2): 236-245. DOI: 10.1002/uog.17468.
[34]
Ahmad MU, Sharif KA, Qayyum H, et al. Assessing the use of magnetic resonance imaging virtopsy as an alternative to autopsy: a systematic review and Meta-analysis[J]. Postgrad Med J, 2017, 93(1105): 671-678. DOI: 10.1136/postgradmedj-2017-134945.
[35]
Jawad N, Sebire NJ, Wade A, et al. Body weight lower limits of fetal postmortem MRI at 1.5 T[J]. Ultrasound Obstet Gynecol, 2016, 48(1): 92-97. DOI: 10.1002/uog.14948.
[36]
Arthurs OJ, Thayyil S, Pauliah SS, et al. Diagnostic accuracy and limitations of post-mortem MRI for neurological abnormalities in fetuses and children[J]. Clin Radiol, 2015, 70(8): 872-880. DOI: 10.1016/j.crad.2015.04.008.
[1] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[2] 贾春岩, 李月河. 涎腺腺泡细胞癌的超声表现及病理对照分析[J]. 中华医学超声杂志(电子版), 2023, 20(04): 462-466.
[3] 康一坤, 袁芃. 三阴性乳腺癌分子遗传学及临床特征研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 290-293.
[4] 王雪菲, 海琳悦, 李立方, 肖春花. Luminal A型乳腺癌的内分泌治疗与化疗[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 294-300.
[5] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[6] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[7] 王璐, 樊杨. 子宫内膜癌相关生物标志物研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 511-516.
[8] 陈珊, 胡智强, 张月明, 唐定, 黎蒙, 赵帅. Orai1、Orai3在乳腺癌组织中的表达及与病理学指标的相关性分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 514-517.
[9] 徐瑜杰, 赵国栋. 晚期胃癌治疗方法的研究进展和挑战[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 451-455.
[10] 刘麒, 曾弘, 徐子昕, 方超, 黄铭, 郑俊炯, 吴少旭, 钟广正, 林天歆, 黄健, 董文. 乳头状肾细胞癌单中心11年临床诊治与预后分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 351-355.
[11] 王楚风, 蒋安. 原发性肝癌的分子诊断[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 499-503.
[12] 萨仁高娃, 张英霞, 邓伟, 闫诺, 樊宁. 超声引导下鼠肝消融术后组织病理特征的变化规律及影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 394-398.
[13] 徐军, 姬园园, 陈君平, 王健. 伴菊形团结构的脑膜瘤合并颅骨侵犯一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 916-919.
[14] 连立超, 范子玥, 张昕, 白丽. 尿KIM-1、NGAL、RBP联合检测在慢性乙肝患者早期肾损伤中的预测价值[J]. 中华临床医师杂志(电子版), 2023, 17(04): 414-418.
[15] 黄楠, 肖天池, 曾成粤, 莫乔惠, 张丽嬴, 徐淼源, 邓小燕, 梁晓丽. 基于网络药理学和分子对接探究桑菊感冒颗粒抗甲型H1N1流感的活性成分及作用机制[J]. 中华临床实验室管理电子杂志, 2023, 11(04): 221-229.
阅读次数
全文


摘要